Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Assessing PDL principles and factors

This document includes guidance for companies (applicants) who wish to put forward submissions/applications to request a switch of an ingredient from prescription to non-prescription status.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Ligne directrice sur la modification du statut d’un ingrédient médicinal pour qu’il passe de « sur ordonnance » à « sans ordonnance » : Évaluation des principes et facteurs de la LDO
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2022-03-17 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["changement", "ingrédient médicinal", "prescription à statut de vente libre", "document d'orientation", "évaluation des principes et facteurs de la LDO"], "en": ["switch", "medicinal ingredient", "prescription to non-prescription-status", "guidance document", "assessing PDL principles-and-factors"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source